| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $56.14B | -28.5% |
| Cost of Revenue | $21.98B | -35.3% |
| R&D Expense | $81.0M | +14.1% |
| SG&A Expense | $705.0M | +13.2% |
| Interest Expense | $780.0M | -3.1% |
| Pre-tax Income | $16.29B | -42.3% |
| Income Tax | $5.33B | -44.2% |
| Net Income | $10.96B | -41.3% |
| EPS (Basic) | $9.08 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.63B | -12.7% |
| Short-term Investments | $971.0M | -65.1% |
| Inventory | $1.40B | +14.7% |
| Current Assets | $14.33B | -23.6% |
| Total Assets | $95.92B | +2.2% |
| Current Liabilities | $10.01B | -22.1% |
| Long-term Debt | $17.86B | +10.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.96B | -29.5% |
| Investing Cash Flow | -$12.00B | -37.3% |
| Financing Cash Flow | -$8.66B | +52.0% |
| -37.9% |
| EPS (Diluted) | $9.06 | -37.8% |
| Total Liabilities |
| $46.65B |
| +1.8% |
| Stockholders' Equity | $49.28B | +2.7% |